This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Seoul National University. Active years: 2021-2022.
Company Filing History:
Years Active: 2021-2022
Title: Innovations by Yoon Jeong in Cancer Diagnosis
Introduction
Yoon Jeong is an accomplished inventor based in Suwon, South Korea. He has made significant contributions to the field of cancer diagnosis through his innovative patents. With a total of 2 patents, his work focuses on developing advanced nanocarrier systems for targeted cancer cell labeling.
Latest Patents
Yoon Jeong's latest patents include a "Nanocarrier for selective fluorescence labeling of cancer cell and preparation method therefor." This invention provides a nanocarrier in a micelle structure, which is used in a pharmaceutical composition for cancer diagnosis. The method involves dispersing a water-in-oil nanoemulsion that contains essential ingredients for targeting cancer cells. The nanocarrier is designed to enhance the accuracy of cancer cell identification.
Another notable patent is the "Hydrogel-based nanoemulsion for selectively labeling cancer lesions, and preparation method therefor." This invention relates to a nanoemulsion that comprises an oil component, a surfactant, and an aqueous component. The aqueous component includes a water-soluble active ingredient, a polysaccharide, and hyaluronic acid, which collectively contribute to the effective labeling of cancer lesions.
Career Highlights
Yoon Jeong is affiliated with Seoul National University, where he continues to advance his research in cancer diagnostics. His work is characterized by a commitment to improving the methodologies used in the medical field, particularly in oncology.
Collaborations
Yoon Jeong collaborates with notable colleagues, including Kang Won Lee and Sara Lee. Their combined expertise enhances the research and development of innovative solutions in cancer diagnosis.
Conclusion
Yoon Jeong's contributions to cancer diagnosis through his innovative patents demonstrate his dedication to advancing medical technology. His work not only reflects his expertise but also holds the potential to significantly impact cancer treatment and diagnosis in the future.